Now fully stabilized, this building provides excellent cash flow from credit-worthy tenants in the pharmaceutical R&D and CDMO space. Recent redesign and capital investments have positioned this property to be one of suburban Philadelphia’s highest quality and most cost-effective laboratory/R&D/flex buildings.
